LPL Financial
DTIL icon

LPL Financial’s Precision BioSciences DTIL Stock Holding History

LPL Financial’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
29,006
+15,968
+122% +$112K ﹤0.01% 5665
2026
Q1 		$71.7K Sell
13,038
-1,003
-7% -$4.63K ﹤0.01% 5730
2025
Q4 		$58.4K Buy
14,041
+2,000
+17% +$11.4K ﹤0.01% 5684
2025
Q3 		$66.5K Sell
12,041
-1,400
-10% -$6.7K ﹤0.01% 5594
2025
Q2 		$56.5K Buy
+13,441
New +$66.3K ﹤0.01% 5349
2024
Q1 		– Sell
-622
Closed -$6.81K – 4949
2023
Q4 		$6.81K Sell
622
-847
-58% -$9.13K ﹤0.01% 4767
2023
Q3 		$15K Buy
1,469
+30
+2% +$461 ﹤0.01% 4630
2023
Q2 		$22.7K Buy
1,439
+479
+50% +$11K ﹤0.01% 4508
2023
Q1 		$21.7K Buy
960
+363
+61% +$12K ﹤0.01% 4401
2022
Q4 		$21.3K Buy
+597
New +$23.6K ﹤0.01% 4355

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

LPL Financial's DTIL Position: Q2 2026 in Review

LPL Financial increased its Precision BioSciences (DTIL) stake by 122% in Q2 2026, buying an estimated $112K and bringing the position to 29,006 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #5665.

LPL Financial first reported a position in DTIL in Q4 2022 and has held it in 10 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • LPL Financial held 29,006 shares of Precision BioSciences worth $228K as of Q2 2026.
  • LPL Financial bought 15,968 Precision BioSciences shares in Q2 2026, an estimated $112K.
  • Precision BioSciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5665 holding.
  • LPL Financial first reported a position in Precision BioSciences in Q4 2022 and has held it in 10 quarters since.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.